secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scilex Holding Co (SCLX)
CIK:        0001820190
Form:       8-K
Filed at:   2024-04-16T23:59:59+00:00
Accession:  0001193125-24-097730
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scilex prelim Q1: ZTlido gross sales $34-38M (+24-38% YoY); net sales $12-13M (+13-23% YoY)
--------------------------------------------------------------------------------

- ZTlido gross sales Q1 2024 estimated $34-38M vs $27.5M Q1 2023, up 24-38%.
- ZTlido net sales Q1 2024 estimated $12-13M vs $10.6M Q1 2023, up 13-23%.
- Company plans to cut R&D and admin expenses in 2024; focuses on late-stage pipeline like SP-102.
- Change Healthcare co-pay processing for ZTlido restored to normal after cyber disruption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1820190/000119312524097730/0001193125-24-097730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1820190/000119312524097730/d815788d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-097730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer